NFKB1 and atherosclerosis: In addition to the lipid-lowering effects, statins also possess anti-inflammatory effects, and it was reported that the inhibitory effects of statins on TLR4/NF-κB and NLRP3 inflammasome pathways contributed to the treatment of atherosclerosis and other inflammation-driven diseases [33–35].